Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Opsens Inc
T.OPS
Healthcare
Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR...
) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:OPS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(8)
•••
Redj4444
X
View Profile
View Bullboard History
Post by
Redj4444
on Jul 29, 2022 12:42pm
Bientot $2,30
Il est encore reparti vers $2,30. Tres instable, pas assez de volume
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Post by
ivebeenthere
on Jul 26, 2022 8:00pm
TD Conference Call Participant
I sent an email to Jeffrey Schacter,the TD analyst who was participating in the conference call.I asked him if he was planning to publish a research about Opsens on the WebBroker site. He will most
...more
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(5542)
•••
retiredcf
X
View Profile
View Bullboard History
Comment by
retiredcf
on Jul 22, 2022 6:19am
RE:A game changer....FDA approval
Added a few more yesterday on the dip. GLTA
(27)
•••
bossu
X
View Profile
View Bullboard History
Post by
bossu
on Jul 21, 2022 11:43am
A game changer....FDA approval
From the last CC: ''n regards to the FDA clearance, since the last call, we had a Q-Sub meeting with the FDA to discuss our proposed answers on last questions remaining. The Q-Sub meeting
...more
(5542)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Jul 21, 2022 9:01am
Slow and Steady
We could use more trading volume but we are slowly and surely heading in the right direction. And since this week began, it's beginning to look like markets may have bottomed. GLTA
(6)
•••
jelliedeeel
X
View Profile
View Bullboard History
Post by
jelliedeeel
on Jul 20, 2022 10:56am
Strong buy on tradingview.com
Technical indicators strong! https://www.tradingview.com/symbols/TSX-OPS/
(6)
•••
jelliedeeel
X
View Profile
View Bullboard History
Post by
jelliedeeel
on Jul 20, 2022 10:44am
Bid only on NEO... no ask! Looking good!
https://www.neo.inc/en/live/security-activity/OPS#!/market-depth
(1489)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Jul 18, 2022 1:09pm
Raymond James - cantechletter
We’re still bullish on Opsens, says Raymond James By Nick Waddell Published on July 18, 2022 Last Updated on July 18, 2022 Filed under: All posts, Analysts
...more
(5542)
•••
retiredcf
X
View Profile
View Bullboard History
Comment by
retiredcf
on Jul 18, 2022 10:23am
RE:RE:RE:RE:RE:Conference call
And yet despite this excellent CC, we're one of the few companies in the red this morning. Clearly it reinforces the old saying that "the market can remain irrational longer than the investor
...more
(27)
•••
bossu
X
View Profile
View Bullboard History
Post by
bossu
on Jul 18, 2022 9:35am
About the CC and comments from analysts
in summary a Great Conference Conference Call Participants Comments Rahul Sarugaser - Raymond James Ltd. Very well done Congrats
...more
(5542)
•••
retiredcf
X
View Profile
View Bullboard History
Comment by
retiredcf
on Jul 18, 2022 8:47am
RE:RE:RE:RE:Conference call
No sign of any report from TD but their participation in the CC may indicate that they are considering initiating coverage. GLTA
(5542)
•••
retiredcf
X
View Profile
View Bullboard History
Comment by
retiredcf
on Jul 18, 2022 7:39am
RE:RE:RE:Conference call
A good read. As everyone could see, we had analysts from six firms. The current targets I have from these firms are $3.35 (Stifel), $4.00 (RBC and MPartners), $4.10 (Paradigm) and $6.00 (Raymond James
...more
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Comment by
ivebeenthere
on Jul 17, 2022 9:06pm
RE:RE:Conference call
Thank you for posting the written form of the conference call. It's way easier to comprehend everything that was said.
(1489)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Comment by
Possibleidiot01
on Jul 17, 2022 3:56pm
RE:Conference call
Analysts seemed interested IMO Opsens Inc. (OPSSF) CEO Louis Laflamme on
...more
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Post by
ivebeenthere
on Jul 17, 2022 11:43am
Conference call
In the question period at the conference call Mister Louis Laflamme said that there is two questions that the FDA want answers . The first one refers to Bio compatibility of the product. To that Mr
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results